World's Best Scientists 2026 revealed!
Federica Cavallo

Federica Cavallo

D-Index & Metrics

Biology and Biochemistry

D-Index
76
Citations
21094
World Ranking
5040
National Ranking
111

Medicine

D-Index
77
Citations
22228
World Ranking
18413
National Ranking
740

Federica Cavallo publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Federica Cavallo sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 451 publications — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Federica Cavallo D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Federica Cavallo sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 76 D-Index — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Federica Cavallo is affiliated with the University of Turin in Italy and has a significant academic presence mainly in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research spans key subfields including Immunology, Oncology, Molecular Biology, Genetics, and Pulmonary and Respiratory Medicine.

Their work covers several main topics, such as Immunotherapy and Immune Responses, Virus-based Gene Therapy Research, Cancer Immunotherapy and Biomarkers, Lymphoma Diagnosis and Treatment, Cancer Cells and Metastasis, Veterinary Oncology Research, and Immune Cells in Cancer.

Frequent coauthors contributing to their publications include Laura Conti, Federica Riccardo, Elisabetta Bolli, Elena Quaglino, and Lidia Tarone.

Federica Cavallo has published extensively in several journals, with notable frequent publication venues including Hematological Oncology, Blood, Cancers, Frontiers in Oncology, and the International Journal of Molecular Sciences.

Among their recent papers are:

  • "Evaluation of Bone Age in Children: A Mini-Review" (2021) published in Frontiers in Pediatrics
  • "The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy" (2021) published in Frontiers in Oncology
  • "Non-Melanoma Skin Cancers: Biological and Clinical Features" (2020) published in International Journal of Molecular Sciences
  • "Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy" (2021) published in mAbs
  • "Toll-Like Receptor 2 at the Crossroad between Cancer Cells, the Immune System, and the Microbiota" (2020) published in International Journal of Molecular Sciences

Best Publications

  • A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction.

    Giuliana Pelicci;Luisa Lanfrancone;Francesco Grignani;Jane McGlade

  • Autologous transplantation and maintenance therapy in multiple myeloma

    Antonio Palumbo;Federica Cavallo;Francesco Di Raimondo

  • Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation.

    Ichiro Hanamura;James P. Stewart;James P. Stewart;Yongsheng Huang;Yongsheng Huang;Fenghuang Zhan;Fenghuang Zhan

  • Classification of current anticancer immunotherapies

    Lorenzo Galluzzi;Erika Vacchelli;José Manuel Bravo-San Pedro;Aitziber Buqué

  • Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial.

    Antonio Palumbo;Sara Bringhen;Anna M. Liberati;Tommaso Caravita

  • Vaccines for tumour prevention

    Pier-Luigi Lollini;Federica Cavallo;Patrizia Nanni;Guido Forni

  • Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice

    Katia Boggio;Giordano Nicoletti;Emma Di Carlo;Federica Cavallo

  • 2011: the immune hallmarks of cancer

    Federica Cavallo;Carla De Giovanni;Patrizia Nanni;Guido Forni

  • Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial

    Antonio Palumbo;Sara Bringhen;Maria Teresa Petrucci;Pellegrino Musto

  • Complete response correlates with long-term progression-free and overall survival in elderly myeloma treated with novel agents: analysis of 1175 patients

    Alessandra Larocca;Pierre Wijermans;Federica Cavallo

  • Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted Myeloma

    Marco Ladetto;Gloria Pagliano;Simone Ferrero;Federica Cavallo

  • Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide

    Alessandra Larocca;Federica Cavallo;Sara Bringhen;Francesco Di Raimondo

  • Zoledronic acid repolarizes tumour‐associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway

    Marta Coscia;Elena Quaglino;Manuela Iezzi;Claudia Curcio

  • Combined Allogeneic Tumor Cell Vaccination and Systemic Interleukin 12 Prevents Mammary Carcinogenesis in HER-2/neu Transgenic Mice

    Patrizia Nanni;Giordano Nicoletti;Carla De Giovanni;Lorena Landuzzi

  • Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial

    Nagesh Kalakonda;Marie Maerevoet;Federica Cavallo;George Follows

  • Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, and gamma-interferon gene or admixed with conventional adjuvants.

    Alessandra Allione;Manuela Consalvo;Patrizia Nanni;Pier Luigi Lollini

  • Role of neutrophils and CD4+ T lymphocytes in the primary and memory response to nonimmunogenic murine mammary adenocarcinoma made immunogenic by IL-2 gene.

    Federica Cavallo;Mirella Giovarelli;Alberto Gulino;Alessandra Vacca

  • Local release of IL-10 by transfected mouse mammary adenocarcinoma cells does not suppress but enhances antitumor reaction and elicits a strong cytotoxic lymphocyte and antibody-dependent immune memory.

    M Giovarelli;P Musiani;A Modesti;P Dellabona

  • Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma

    Antonio Palumbo;Maria Teresa Ambrosini;Giulia Benevolo;Patrizia Pregno

  • CYTOKINES, TUMOUR-CELL DEATH AND IMMUNOGENICITY : A QUESTION OF CHOICE

    Piero Musiani;Andrea Modesti;Mirella Giovarelli;Federica Cavallo

Frequent Co-Authors

Guido Forni
Guido Forni University of Turin
Mario Boccadoro
Mario Boccadoro University of Turin
Antonio Palumbo
Antonio Palumbo University of Turin
Piero Musiani
Piero Musiani University of Chieti-Pescara
Raffaele A. Calogero
Raffaele A. Calogero University of Turin
Pellegrino Musto
Pellegrino Musto University of Bari Aldo Moro
Mirella Giovarelli
Mirella Giovarelli University of Turin
Umberto Vitolo
Umberto Vitolo University of Turin
Patrizia Nanni
Patrizia Nanni University of Bologna
Paolo Corradini
Paolo Corradini University of Milan

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA opens doors to many interdisciplinary career paths. Today, flexible education options make it easier to pursue specialized roles in healthcare, research, and nutrition—often without ever stepping foot on campus. Choosing the right online program is crucial. Cost, program length, and accreditation are key factors to consider.

For those interested in nutrition, an online dietitian degree can pave the way to roles such as licensed nutritionist or dietitian, while offering affordability and convenience. Registered nurses wishing to advance their qualifications can investigate rn to bsn online programs, which provide accelerated routes to higher credentials.

If your interests include healthcare leadership or administration, consider an accelerated healthcare management degree online, designed for busy professionals. Alternatively, students aiming to enter mental health nursing fields may explore accelerated msn psychiatric np programs to quickly gain specialized clinical skills.

These online pathways offer flexibility and targeted expertise—helping students seamlessly move from foundational science degrees to rewarding careers across the health and life sciences.

Best Scientists Citing Federica Cavallo

Trending Scientists

Recently Published Articles